Sunday, August 24, 2008
All for the money!
For some reason I found this hilarious:
But at least it's good for the drug companies.
Meanwhile, the vaccines’ proponents are moving to the next frontier: older women and boys. Merck recently applied for approval to market the vaccine to women 26 to 45 and is conducting studies on vaccinating boys, who can get genital warts from HPV.
One rationale for inoculating boys is that entire populations should be vaccinated to achieve what is called herd immunity. But critics ask whether it is worth conducting a campaign on the scale of the one used against polio to eliminate a generally harmless virus.
Said Dr. Raffle, the British cervical cancer specialist: “Oh, dear. If we give it to boys, then all pretense of scientific worth and cost analysis goes out the window.”
But at least it's good for the drug companies.
